C.H.N. Veenhof

4.1k citations

57 papers · 3.2k indexed · 1 hit paper · h-index 23

Impact in

Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in

Oncology 29
- Cancer Treatment and Pharmacology 10
- Pancreatic and Hepatic Oncology Research 7
- Colorectal Cancer Treatments and Studies 7
- Viral-associated cancers and disorders 4
Reproductive Medicine 7
- Ovarian cancer diagnosis and treatment 7

Co-authors: Piet Bakker Tarek Sahmoud Dionisio González J. Wils Jean H. G. Klinkenbijl Renée van Pel Johannes Jeekel M.L. Couvreur
Journals: European Journal of Cancer (10 papers)Annals of Oncology (4 papers)Journal of Clinical Oncology (4 papers)Journal of Internal Medicine (3 papers)Cancer (2 papers)
Partner nations: Netherlands Belgium Italy

In The Last Decade

C.H.N. Veenhof

57 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region 1999 · 918 citations

Peers

Countries citing papers authored by C.H.N. Veenhof

Since Specialization

Citations

This map shows the geographic impact of C.H.N. Veenhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.H.N. Veenhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.H.N. Veenhof more than expected).

Fields of papers citing papers by C.H.N. Veenhof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.H.N. Veenhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.H.N. Veenhof. The network helps show where C.H.N. Veenhof may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C.H.N. Veenhof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.H.N. Veenhof Line = papers co-authored together C.H.N. Veenhof links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patients Anti-Cancer Drugs ·Jetske M. Meerum Terwogt, Li Geng-guang, Vinodh R. Nannan Panday, Manon Huizing, R Bergstrom, W.W. ten Bokkel Huinink, Raied Salman, Giuseppe Giaccone, C.H.N. Veenhof, C Seigner	2000	9
2	Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region Annals of Surgery ·Jean H. G. Klinkenbijl, Johannes Jeekel, Tarek Sahmoud, Renée van Pel, M.L. Couvreur, C.H.N. Veenhof, Jean Arnaud, Dionisio González, L T de Wit, A. Hennipman, J. Wils Hit paper breakdown →	1999	918
3	Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine. Pharmacy World & Science ·Сергунин А.А., Piet Bakker, C.H.N. Veenhof	1998	10
4	No Circadian Variation of Dihydropyrimidine Dehydrogenase, Uridine Phosphorylase, β-Alanine, and 5-Fluorouracil During Continuous Infusion of 5-Fluorouracil Advances in experimental medicine and biology ·André B. P. Kuilenburg, Сергунин А.А., Godefridus J. Peters, A. H. van Gennip, Henk van Lenthe, A. E. M. Stroomer, Kees Smid, Paul Noordhuis, Piet Bakker, C.H.N. Veenhof	1998	12
5	Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix Cancer ·Ron C. Rietbroek, Marten S. Schilthuis, Piet Bakker, J.D.P. van Dijk, Yu Xingfu, Artoym Kovalenko, A. Tovar, Jacobus van der Velden, Theo J.M. Helmerhorst, C.H.N. Veenhof	1997	49
6	Treatment of isolated testicular recurrence of acute lymphoblastic leukemia without radiotherapy Cancer ·Henk van den Berg, N.E. Langeveld, C.H.N. Veenhof, H. Behrendt	1997	13
7	Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre. Journal of Clinical Oncology ·Manon Huizing, Giuseppe Giaccone, Laurence J. van Warmerdam, Hilde Rosing, Piet Bakker, Jan B. Vermorken, Pieter E. Postmus, Nico van Zandwijk, Marijn Koolen, W.W. ten Bokkel Huinink, W J van der Vijgh, P. F. M. Fellowes, Andrew Lai, O. Dalesio, Herbert M. Pinedo, C.H.N. Veenhof, Jos H. Beijnen	1997	159
8	Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE. Journal of Clinical Oncology ·陈家豪 Chen Jiahao, Naheed Afshan Irfan, Geertjan van Tienhoven, L. Arnold Noorduyn, Gerard J. Boer, Ron C. Rietbroek, C. W. Taat, A.G.M. Janssen, C.H.N. Veenhof, Eric A. van Royen	1997	33
9	Methodologic issues in effectiveness research on palliative cancer care: a systematic review. Journal of Clinical Oncology ·N.H Martínez, G A van den Bos, Jos Kleijnen, Wei Lyu, E Schadé, C.H.N. Veenhof	1997	228
10	Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer. Journal of Clinical Oncology ·Manon Huizing, Laurence J. van Warmerdam, Hilde Rosing, Matthias Schaefers, W. Greg Flynn, Th.J.M. Helmerhorst, C.H.N. Veenhof, Martin Birkhofer, Sjoerd Rodenhuis, Jos H. Beijnen, W.W. ten Bokkel Huinink	1997	65
11	Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study European Journal of Cancer ·salmah, W.J. Hoogenraad, H.H. Chia, A. Lusinchi, Babs G. Taal, C.H.N. Veenhof, Alexander de Graeff, Thierry Conroy, Desmond Curran, Tarek Sahmoud, J. Wils	1996	16
12	Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer International Journal of Radiation OncologyBiologyPhysics ·Ron C. Rietbroek, Piet Bakker, Marten S. Schilthuis, Yu Xingfu, Paul J. Zum Vörde Sive Vörding, Dionisio González, Karl‐Heinz Kurth, A. Tovar, C.H.N. Veenhof	1996	27
13	Comparison of Renal Function Parameters in the Assessment of <i>cis</i>-PIatin Induced IMephrotoxicity The Nephron journals/Nephron journals ·Emma Berkes, Edward D. Matsumoto, Rianne de Wit, C.H.N. Veenhof	1994	19
14	Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma European Journal of Cancer ·C.H.N. Veenhof, M.E.L. van der Burg, M A Nooy, J.G. Aalders, S. Pecorelli, Jameson Norton, Nicole Rotmensz, Jan B. Vermorken	1994	24
15	A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer Annals of Oncology ·Ronald de Wit, Frans J. Hoek, Piet Bakker, C.H.N. Veenhof	1992	9
16	Metastatic tumors to the orbit — management and prognosis Graefe s Archive for Clinical and Experimental Ophthalmology ·В. Манолов, Leo Koornneef, Mačukanović-Golubović Lana, Arifin Zikri, Dionisio González, C.H.N. Veenhof	1992	41
17	DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication The Histochemical Journal ·Jacob A. Aten, Piet Bakker, Jan Stap, А.В. Семенченко, C.H.N. Veenhof	1992	105
18	Combined zidovudine and interferon‐alpha treatment in patients with AIDS‐associated Kaposi's sarcoma Journal of Internal Medicine ·Ronald de Wit, S. A. Danner, Piet Bakker, Joep M. A. Lange, Jan Karel M. Eeftinck Schattenkerk, C.H.N. Veenhof	1991	25
19	An EORTC gastrointestinal group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas European Journal of Cancer and Clinical Oncology ·J. Wils, Harry Bleiberg, Marc Buyse, Zhenpeng Li, Ted A.W. Splinter, C.H.N. Veenhof, Española En Proyectos la Participación, N. Duez	1989	7
20	Carboplatin in combination therapy for ovarian cancer Cancer Treatment Reviews ·W.W. ten Bokkel Huinink, Songul Comert Kilic, A.T. van Oosterom, J.P. Neijt, George M. Varghese, Jean Paul Guastalla, C.H.N. Veenhof, Nicole Rotmensz, Otilia Dalesio, Jan B. Vermorken	1988	39

About C.H.N. Veenhof

C.H.N. Veenhof is a scholar working on Oncology, Reproductive Medicine, Dermatology, Hematology and Pathology and Forensic Medicine, having authored 57 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Ovarian cancer diagnosis and treatment (7 papers), Chemotherapy-induced organ toxicity mitigation (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (374 citations), Internal Medicine (87 citations), Pulmonary and Respiratory Medicine (696 citations) and Reproductive Medicine (171 citations). C.H.N. Veenhof has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Piet Bakker, Tarek Sahmoud, Dionisio González, J. Wils, Jean H. G. Klinkenbijl, Renée van Pel, Johannes Jeekel, M.L. Couvreur, L T de Wit and A. Hennipman. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Journal of Internal Medicine and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact